Sysmex (OTCMKTS:SSMXY) Shares Gap Down – Should You Sell?

Sysmex Corporation ADR (OTCMKTS:SSMXY)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $9.87, but opened at $9.5101. Sysmex shares last traded at $9.83, with a volume of 109,974 shares.

Analyst Upgrades and Downgrades

Separately, The Goldman Sachs Group upgraded shares of Sysmex from a “hold” rating to a “buy” rating in a research report on Thursday, October 9th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy”.

Sysmex Stock Down 0.6%

The company has a current ratio of 3.34, a quick ratio of 2.49 and a debt-to-equity ratio of 0.11. The company has a 50 day simple moving average of $10.18 and a two-hundred day simple moving average of $12.97. The firm has a market capitalization of $6.18 billion, a P/E ratio of 19.63 and a beta of 1.17.

Sysmex (OTCMKTS:SSMXY) last released its earnings results on Wednesday, November 5th. The company reported $0.16 EPS for the quarter, hitting the consensus estimate of $0.16. The firm had revenue of $826.60 million for the quarter, compared to the consensus estimate of $880.80 million. Sysmex had a net margin of 9.32% and a return on equity of 9.86%. On average, equities analysts predict that Sysmex Corporation ADR will post 0.57 EPS for the current fiscal year.

About Sysmex

Sysmex Corporation (OTCMKTS: SSMXY) is a Japan‐based provider of in vitro diagnostic solutions, specializing in haematology, coagulation, urinalysis and immunochemistry systems. Headquartered in Kobe, the company designs and manufactures a comprehensive portfolio of automated analyzers, reagents and software to support clinical laboratories, hospitals and research institutions. Sysmex’s product lineup also includes digital pathology platforms and data management tools that integrate workflow automation and advanced analytics.

The company’s core offerings center on haematology analyzers such as the XN-Series, which deliver high‐speed, high‐volume testing for blood cell counts and differential analysis.